Trace amine associated receptor agonists are going to be a good choice in the pharmacological management of Schizophrenia. There will be less side effects and better efficacy. Will these group of medicines completely replace other antipsychotics, including clozapine, in the market?
Bhogaraju Anand
Hi,
Schizophrenia is such a complex disorder with Neurodevelopment etiology mostly holding fort.TAAR1 agonists have to be compared with existing antipsychotics and then we can examine the evidence. Initial interest needs to be sustained
1 votes
0 thanks
More Anuradha Ellepola's questions See All
Similar questions and discussions